Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2000
06/14/2000EP1007567A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
06/14/2000EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
06/14/2000EP1007551A2 Vaccine against hpv
06/14/2000EP1007547A1 Peptides comprising a t-cell epitope specific to collagen ii
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007534A1 Bh3 interacting domain death agonist
06/14/2000EP1007093A1 Methods for treating disorders by using interleukin-9 and its antagonists
06/14/2000EP1007092A1 A process for inhibiting complement activation via the alternative pathway
06/14/2000EP1007090A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
06/14/2000EP1007088A1 Recombinant porcine adenovirus vector
06/14/2000EP1007083A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
06/14/2000EP1007069A1 Novel coding sequences
06/14/2000EP1007067A1 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium
06/14/2000EP1007047A1 Use of mizolastine for preparing a medicine for treating inflammation
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP1007020A1 Treatment of cell-mediated immune diseases
06/14/2000EP1006782A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
06/14/2000EP0754193B1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
06/14/2000CN1256695A Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
06/14/2000CN1053441C Compound with 1-(aryl china olefine)-4-(aryl methyl) piperazine structure, its preparation process and medicine containing the compound thereof
06/14/2000CN1053380C Injection for curing AIDS
06/14/2000CN1053379C Linghuang oral liquid made from Goboderma lucidum andscutellaria root
06/14/2000CN1053371C Extraction of Fructus Corni with immunosuppression and prep. therefor
06/14/2000CN1053367C Health wine and its prep. process
06/14/2000CN1053365C Nutrient for youngsters
06/14/2000CN1053352C Health medicinal liquor
06/13/2000US6075150 A cell antiproliferative agent
06/13/2000US6075119 Particles useful in the prevention and treatment of staphylococcal or streptococcal infection
06/13/2000US6075020 Method of regulating immune function
06/13/2000US6074650 Membrane anchor/active compound conjugate, its preparation and its uses
06/13/2000US6074644 Cytotoxic activity
06/13/2000US6074642 Reduce cell lysing ability of biological complement present in blood
06/13/2000US6074635 T cell activation
06/13/2000CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
06/13/2000CA2085878C Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylidene and piperazine compounds and compositions
06/13/2000CA2077537C Therapeutically useful peptides and peptide fragments
06/13/2000CA2036398C Hiv protease inhibiting agents
06/13/2000CA1341027C Phosphonoalkylpurine derivatives
06/13/2000CA1341026C Il-1 inhibitors process for producing il-1 inhibitors and for using such inhibitors in therapy
06/08/2000WO2000033069A1 Substance containing shiitake mushroom hypha extract for screening lak activity and method for screening lak activity by using the same
06/08/2000WO2000032818A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression
06/08/2000WO2000032816A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000WO2000032767A1 RECOMBINANT SOLUBLE Fc RECEPTORS
06/08/2000WO2000032764A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000WO2000032634A1 Humanized antibodies to gamma-interferon
06/08/2000WO2000032632A2 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use
06/08/2000WO2000032620A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000WO2000032584A2 Nonsteroidal antiinflammatories
06/08/2000WO2000032575A1 β-ALANINE DERIVATIVES AS α4 INTEGRIN INHIBITORS
06/08/2000WO2000032570A1 Hydrazine derivatives
06/08/2000WO2000032567A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
06/08/2000WO2000032235A1 Transport system conjugate
06/08/2000WO2000032234A1 Topical compositions comprising ascomycins
06/08/2000WO2000032231A1 Stimulation of t cells against self antigens using ctla-4 blocking agents
06/08/2000WO2000032229A1 Preparations containing virus-like particles as immunopotentiators administered through the mucosa
06/08/2000WO2000032227A2 Ordered molecular presentation of antigens, method of preparation and use
06/08/2000WO2000032223A2 Therapeutic treatment with immunogenic drugs
06/08/2000WO2000032219A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
06/08/2000WO2000032213A1 ηδT CELL IMMUNOACTIVITY POTENTIATORS CONTAINING SHIITAKE MUSHROOM HYPHA EXTRACT
06/08/2000WO2000032212A1 Lak activity potentiator orginating in shiitake mushroom hyphae extract and lak activity potentiating preparations containing the same
06/08/2000WO2000032209A2 Submucosa modulation of mammalian immune response
06/08/2000WO2000032205A1 Immunomodulatory methods using carbohydrate antigens
06/08/2000WO2000032194A2 Use of niacin for the prevention of photocarcinogenesis and photoimmunosuppression
06/08/2000WO2000032189A1 Celecoxib compositions
06/08/2000WO2000032173A1 Improved dissolution of triprolidine hydrochloride
06/08/2000WO2000032168A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases
06/08/2000WO2000016760A3 New use of prostaglandin e2 antagonists
06/08/2000WO2000009103A9 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders
06/08/2000WO2000008191A3 Herpes virus vectors for dendritic cells
06/08/2000WO2000004137A9 Human aspartic proteases
06/08/2000WO1999058095A3 Pharmaceutical and/or cosmetic compositions containing sea water
06/08/2000DE19856463A1 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors
06/08/2000CA2354183A1 Ordered molecular presentation of antigens, method of preparation and use
06/08/2000CA2353550A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000CA2353502A1 Immunomodulatory methods using carbohydrate antigens
06/08/2000CA2353402A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
06/08/2000CA2353108A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression
06/08/2000CA2353090A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000CA2353079A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000CA2352785A1 Submucosa modulation of mammalian immune response
06/08/2000CA2352555A1 Transport system conjugate
06/08/2000CA2352539A1 Recombinant soluble fc receptors
06/08/2000CA2352512A1 Lak activity enhancers derived from extract of lentinus endodes mycelium and lak activity-enhancers formulations containing the extract
06/08/2000CA2352487A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases
06/08/2000CA2352459A1 .gamma..delta.t cell immunoactivity enhancers containing extract of lentinus edodes mycelium
06/08/2000CA2352388A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000CA2352367A1 Nonsteroidal antiinflammatories
06/08/2000CA2351321A1 Hydrazine derivatives
06/08/2000CA2348823A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000CA2347701A1 .beta.-alanine derivatives as .alpha.4 integrin inhibitors
06/07/2000EP1006196A2 Retroviral hybrid vectors pseudotyped with LCMV glycoprotein
06/07/2000EP1006183A1 Recombinant soluble Fc receptors
06/07/2000EP1005871A2 Trapped cells and use thereof as a drug
06/07/2000EP1005866A2 Allogeneic and xenogeneic transplantation
06/07/2000EP1005550A1 Ubc7-like ubiquitin-conjugating enzyme
06/07/2000EP1005493A1 Antiviral protease inhibitors
1 ... 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 ... 1172